Isocitrate dehydrogenase 1 and 2 mutations, 2-hydroxyglutarate levels, and response to standard chemotherapy for patients with newly diagnosed acute myeloid leukemia
Suzhen Wang of the department of Health Statistics, Shandong Second Medical University, for her guidance on statistical methodology
In PD, the initiating pathology is the misfolding of -synuclein in dopaminergic neurons of the substantia nigra, leading to Lewy body formation and neuronal death (90, 91)
Some of the best foods containing high concentrations of glutathione are mushrooms, spinach, okra, turmeric, asparagus, avocados and other sulfur-containing foods
Groll M, Kim KB, Kairies N, Huber R, Crews CM

translation to dogs is uncertain Lack of clinical trials: No published randomized controlled trials in dogs Regulatory status: Not approved by FDA or veterinary regulatory agencies Quality control: Variability in peptide quality from research suppliers Optimal protocols: Dose, frequency, duration, and timing relative to injury not established for dogs Outcome measures: Standardized assessment of improvement in dogs lacking Long-term effects: Unknown effects of chronic use in companion animals Complementary Approaches to Canine Orthopedic Care Established evidence-based interventions for canine orthopedic conditions include: Weight management: Critical for reducing joint stress and improving outcomes Physical rehabilitation: Therapeutic exercises, hydrotherapy, and passive range of motion NSAIDs: Carprofen, meloxicam, and other veterinary anti-inflammatories Joint supplements: Glucosamine, chondroitin sulfate, omega-3 fatty acids Regenerative medicine: Platelet-rich plasma (PRP), stem cell therapy Surgical interventions: Various procedures depending on specific condition Assistive devices: Braces, slings, carts for mobility support Acupuncture and laser therapy: Adjunctive pain management modalities The Veterinary Research Landscape Peptide research in veterinary medicine faces unique challenges: Limited funding compared to human medical research Smaller market size for veterinary pharmaceuticals Regulatory pathways less established than for human drugs Ethical considerations for experimental treatments in companion animals Need for breed-specific and size-specific data given canine diversity Despite these challenges, there is growing interest in translating peptide research to veterinary applications, particularly for conditions with limited treatment options
